The integration of automation in proteomic liquid chromatography-mass spectrometry (LC-MS) laboratories has been historically slow, hindered by the absence of versatile, user-friendly, and cost-effective systems. However, recent technological advancements, such as the Andrew+ Robot, are revolutionizing the field by offering intuitive solutions for automating complex liquid handling tasks with exceptional precision.
This webinar will explore how our team leveraged the Andrew+ Robot during the COVID-19 pandemic to develop an LC-MS-based assay for SARS-CoV-2 screening in nasopharyngeal swabs using the Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA) methodology. The system’s flexibility enabled us to adapt workflows for diverse applications, including human plasma sample analysis and the measurement of mRNA vaccine transfection efficiency in human cell lines.
Additionally, we will discuss the automation of widely used proteomic methodologies, such as single-pot, solid-phase-enhanced sample preparation (SP3) and suspension trapping, utilizing connected devices like Magnet+ and Extraction+. These advancements have enabled high-throughput processing of samples with exceptional reproducibility and precision, facilitating large-scale studies with robust data quality.
Join us to learn how the adoption of automation technologies not only reduces manual intervention but also accelerates advancements in proteomic research, enabling breakthroughs in disease biomarker discovery, vaccine development, and beyond. This session will highlight the transformative potential of automation to enhance efficiency, consistency, and reliability in proteomic workflows.
